痛风的住院治疗:血清尿酸检测和阿洛普林醇剂量调整
Kate Alfeld1, Murray L Barclay2, Richard McNeill2
1K. Alfeld, MBChB, Rheumatology Registrar, Department of Rheumatology, Immunology and Allergy, Te Whatu Ora, Waitaha.
The Journal of rheumatology
|January 15, 2025
概括
服用阿洛普林醇的痛风患者在住院期间很少接受血清尿酸盐 (SU) 测试. 这导致了不理想的痛风管理,表明错过了优化治疗和改善患者治疗结果的机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 临床药房 临床药房
背景情况:
- 尽管有有效的治疗方法,但痛风管理往往不够理想.
- 艾洛普醇是一种常见的尿酸降低治疗痛风.
研究的目的:
- 评估在接受全二醇治疗的住院患者血清尿酸盐 (SU) 检测的频率.
- 评估在住院期间与SU水平相关的阿洛普林醇剂量调整.
主要方法:
- 利用医院的电子处方和管理 (ePA) 系统来识别服用阿洛普醇的患者.
- 收集了关于人口统计,SU水平,功能和阿洛普林醇治疗变化的数据.
- 根据目标SU和慢性病 (CKD) 阶段分层结果.
主要成果:
- 血清尿酸仅在接受全普林醇治疗的18081名患者中测量了16.32%.
- 超过43%的测量SU水平超过了0.36 mmol/L的目标.
- 患有晚期CKD (3-5期) 的患者更有可能患有超过目标的SU,并停止或减少Allopurinol.
结论:
- 住院患者经常缺乏对所有普林醇患者的血清尿酸监测.
- 艾洛普里诺尔剂量往往低于最佳,无法与测量的SU水平保持一致.
- 这些发现突出了优化住院患者痛风管理的重大错失机会.
相关概念视频
Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
Peptic Ulcer Disease IV: Management
71
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
71
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Phase II Reactions: Glucuronidation
264
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
264
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Factors Affecting Renal Clearance: Renal Impairment
52
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
52


